BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15904)

  • 21. Effects of contraceptive pills and intrauterine devices on urinary bladder.
    Zahran MM; Osman MI; Kamel M; Fayad M; Mooro H; Youssef AF
    Urology; 1976 Dec; 8(6):567-74. PubMed ID: 793141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
    Barbosa J; Seal US; Doe RP
    J Clin Endocrinol Metab; 1973 Apr; 36(4):706-14. PubMed ID: 4119677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiamine status and oral contraceptives.
    Briggs MH; Briggs M
    Contraception; 1975 Feb; 11(2):151-4. PubMed ID: 1112084
    [No Abstract]   [Full Text] [Related]  

  • 26. Adrenocortical function of patients using oral contraceptives.
    Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
    Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of oral contraceptive agents on copper and zinc balance in young women.
    Crews MG; Taper LJ; Ritchey SJ
    Am J Clin Nutr; 1980 Sep; 33(9):1940-5. PubMed ID: 7416062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of oral contraceptives on vitamin B6 nutriture of young women.
    Vir SC; Love AH
    Int J Vitam Nutr Res; 1980; 50(1):29-34. PubMed ID: 7390712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. I. Blood and urinary lactate, uric acid, and phosphorus.
    Kelsay JL; Behall KM; Moser PB; Prather ES
    Am J Clin Nutr; 1977 Dec; 30(12):2016-22. PubMed ID: 930871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oral contraceptive agents on nutrients: I. Minerals.
    Prasad AS; Oberleas D; Moghissi KS; Lei KY; Stryker JC
    Am J Clin Nutr; 1975 Apr; 28(4):377-84. PubMed ID: 1119434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA; Brenner PF; Kletzky OA; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
    El Hakim SM; Abdin FH; Kandil O
    Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-term triphasic oral contraceptive use on glucose tolerance and insulin secretion.
    Gillespy M; Notelovitz M; Ellingson AB; Khan FY
    Obstet Gynecol; 1991 Jul; 78(1):108-14. PubMed ID: 2047050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
    Kay CR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):762-5. PubMed ID: 6801981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review.
    Korba VD; Heil CG
    Fertil Steril; 1975 Oct; 26(10):973-81. PubMed ID: 1183625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant hypertension and oral contraceptives: four cases, with two due to the 30 micrograms oestrogen pill.
    Hodsman GP; Robertson JI; Semple PF; Mackay A
    Eur Heart J; 1982 Jun; 3(3):255-9. PubMed ID: 6809465
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of oral contraceptives on plasma androgenic steroids and their precursors.
    Fern M; Rose DP; Fern EB
    Obstet Gynecol; 1978 May; 51(5):541-4. PubMed ID: 148599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.